Skip to main content
Kristina Deligiannidis, MD, Psychiatry, Glen Oaks, NY, North Shore University Hospital

KristinaM.DeligiannidisMD

Psychiatry • Glen Oaks, NY

Director, Women's Behavioral Health; Professor of Psychiatry, Molecular Medicine and OB-GYN, Zucker School of Medicine at Hofstra-Northwell; Professor, Feinstein Institutes for Medical Research, Northwell Health; Medical Director, Reproductive Psychiatry, Project TEACH NY; Adjunct Professor of Psychiatry, UMass Chan Medical School

Join to view full profile

Dr. Deligiannidis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Deligiannidis' full profile

Already have an account?

Summary

  • Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the NIH. Dr. Deligiannidis completed additional NIH research training during medical school and residency. She received an MD from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institute for Medical Research/Zucker School of Medicine at Hofstra/Northwell in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology.

    Dr. Deligiannidis is the Director of Women’s Behavioral Health at Zucker Hillside Hospital. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle and pregnancy/postpartum periods.

    Dr. Deligiannidis conducts grant-funded research in the causes of perinatal depression and in novel therapeutics. Her research interests include psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in postpartum depression. Dr. Deligiannidis's research efforts have been nationally recognized. She is the recipient of federal, foundation and industry research funding including prestigious K23 and R01 grants from the NIMH and numerous awards for research and teaching of medical students and residents. Dr. Deligiannidis’s research has been covered by major media outlets including the Boston Globe, Boston WCVB ABC News, Boston WBZ CBS News, CBS-2-NY, ABC-7 NY, National Public Radio and Newsday, among others.

    Dr. Deligiannidis actively participates in and holds leadership positions in national scientific committees, gives presentations nationally and serves as grant reviewer for the NIH.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Psychiatry, 2004 - 2009
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2004
  • University of Warwick
    University of WarwickNo degree, Psychology and Neuropsychology, 1997
  • University of Massachusetts Amherst
    University of Massachusetts AmherstB.S., Biology, Magna cum Laude, 1997
  • University of Massachusetts Amherst
    University of Massachusetts AmherstB.S., Psychology, Magna cum Laude, 1997

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2007 - 2018
  • American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

Journal Articles

  • Expression of inflammatory cytokines across gestation in women with symptoms of perinatal depression  
    Buglione-Corbett R, Deligiannidis KM, Leung K, Zhang NN, Rosal M, Moore Simas TA, Archives of Womens Mental Health, 1/1/2018
  • Differential peripartum plasma neuroactive steroid and GABA profiles in healthy women vs women at-risk for developing postpartum depression  
    Deligiannidis KM, Kroll-Desrosiers A, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA, Psychoneuroendocrinology, 1/1/2016
  • Salivary Cortisol Response to the Trier Social Stress Test in Pregnant Women at Risk of Postpartum Depression  
    Deligiannidis KM, Kroll-Desrosiers A, Svenson A, Jaitly, N, Barton BA, Hall JE, Rothschild AJ, Archives of Women�s Mental Health, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Biomarkers of Postpartum Psychiatric Disorders 
    Chapter: Functional MRI biomarkers in perinatal psychiatric disorders 
    Hare M, Duan C, Deligiannidis KMEditors: J Payne.Elsevier2018
  • The Evidence-Based Guide to Antidepressants 
    Chapter: The use of antidepressants in pregnancy and lactation 
    Deligiannidis KMEditors: AJ Rothschild.American Psychiatric Publishing, Inc., Arlington, VA2012
  • The Evidence-Based Guide to Antipsychotics 
    Chapter: The Use of Antipsychotics in Mood and Anxiety Disorders 
    Deligiannidis KM & Rothschild AJEditors: AJ Rothschild.American Psychiatric Publishing, Inc., Arlington, VA2010
  • Join now to see all

Abstracts/Posters

  • Analysis of the efficacy and safety of Brexanolone Injection in subgroups from an integrated dataset of placebo-controlled postpartum depression studies
    40. Meltzer-Brody, S, Kanes S, Riesenberg, Epperson CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Colquhoun H, World Congress on Women’s Mental Health, International Association for Women’s Mental Health, Paris, France, 3/2019
  • Integrated analysis of efficacy as assessed by the Montgomery-Asberg Depression rating scale from three pivotal trials of brexanolone in women with postpartum depression.
    41. Meltzer-Brody, S, Colquhoun H, Riesenberg R, Epperson, CN, Deligiannidis KM, Rubinow D, Li H, Clemson C, Kanes S., 39th Annual Pregnancy Meeting of the Society of Maternal Fetal Medicine,, Las Vegas, NV, 2/2019
  • Functional connectivity, cortical GABA and neuroactive steroids in peripartum and peripartum depressed women
    Deligiannidis KM, Fales, CL, Kroll-Desrosiers, Shaffer SA, Villamarin V, Tan Y, Hall JE, Frederick BB, Sikoglu EM, Edden RA, Rothschild, AJ, Moore CM, American College of Neuropsychopharmacology (ACNP) 57th Annual Meeting, Hollywood, FL, 1/1/2018
  • Join now to see all

Lectures

  • Clinical Update on the Presentation and Treatment of Peripartum Depression 
    Zucker Hillside Hospital, Glen Oaks, NY - 1/1/2018
  • Peripartum Depression: Clinical Update and New Research into Pathophysiology and Treatment 
    New Hyde Park, NY - 1/1/2018
  • Inflammation and the Development of Perinatal Mood and Anxiety Disorders 
    Manhasset, NY - 1/1/2018
  • Join now to see all

Other

Authored Content

  • S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018
  • S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018

Hospital Affiliations

External Links

Dr. Kristina Deligiannidis, Dr. Kristina Deligiannidis, MD, Dr. K Deligiannidis, Dr. Kristina M. Deligiannidis